Growth and Development Group, Vall d'Hebron Institut de Recerca (VHIR)-Pediatric Endocrinology Section, Hospital Universitari Vall d'Hebron (HUVH), 08035 Barcelona, Spain.
CIBERER, ISCIII, 28029 Madrid, Spain.
Int J Mol Sci. 2024 Sep 18;25(18):10032. doi: 10.3390/ijms251810032.
Genetic defects in the TSH receptor () can cause poor thyroid differentiation (thyroid dysgenesis) and/or thyroid malfunction (thyroid dyshormonogenesis). The phenotype spectrum is wide: from severe congenital hypothyroidism to mild hyperthyrotropinemia. Over 250 variants have been published, many uncharacterized in vitro. We aimed to genetically characterize patients with thyroid dyshormonogenesis with defects and to study in vitro the effect of the genetic variants to establish the genotype-phenotype relationship. Pediatric patients with thyroid dyshormonogenesis (160 patients, Catalan CH neonatal screening program, confirmation TSH range: 18.4-100 mIU/L), were analyzed by a high-throughput gene panel. In vitro studies measuring the TSH-dependent cAMP-response-element activation were performed. Five patients with mild or severe thyroid dyshormonogenesis presented six variants, two unpublished. Each variant showed a different in vitro functional profile that was totally or partially deleterious. Depending on the genotype, some of the variants showed partial deficiency in both genotypes, whereas others presented a different effect. In conclusion, the percentage of patients with thyroid dyshormonogenesis and candidate variants in is 3.13%. Our in vitro studies contributed to the confirmation of the pathogenicity of the variants and highlighted the importance of studying the effect of the patient's genotype for a correct diagnostic confirmation.
TSH 受体()的遗传缺陷可导致甲状腺分化不良(甲状腺发育不良)和/或甲状腺功能障碍(甲状腺激素生成障碍)。表型谱很广:从严重的先天性甲状腺功能减退症到轻度促甲状腺素升高。已经发表了超过 250 种变异体,但许多在体外都没有特征。我们旨在通过研究 缺陷导致的甲状腺激素生成障碍患者的遗传特征,并研究体外遗传变异的影响,以建立基因型-表型关系。通过高通量基因面板分析了患有甲状腺激素生成障碍的儿科患者(160 例患者,加泰罗尼亚新生儿筛查计划,确认 TSH 范围:18.4-100mIU/L)。进行了测量 TSH 依赖性 cAMP 反应元件激活的体外研究。五位患有轻度或重度甲状腺激素生成障碍的患者表现出六种 变异,其中两种是未发表的。每种变异体显示出不同的体外功能谱,完全或部分具有致病变异。根据基因型,一些变异体在两种基因型中均表现出部分缺乏,而其他变异体则表现出不同的影响。总之,甲状腺激素生成障碍患者和候选变异体在 中的比例为 3.13%。我们的体外研究有助于确认变异体的致病性,并强调了研究患者基因型对正确诊断确认的重要性。